Dechra Pharmaceuticals PLC Director Declaration (8560Z)
18 March 2017 - 2:17AM
UK Regulatory
TIDMDPH
RNS Number : 8560Z
Dechra Pharmaceuticals PLC
17 March 2017
17 March 2017
Dechra(R) Pharmaceuticals PLC
("Dechra" or "the Company")
Director's Declaration
In accordance with Listing Rule 9.6.14(2) Dechra announces that
Ishbel Macpherson, Non-Executive Director of Dechra, is to be
appointed as a
Non-Executive Director of Fidessa group plc with effect from 1
May 2017.
For further information:
Suzana Cross, Company Secretary and General Counsel
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Its expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDNBUGDXUBBBGRR
(END) Dow Jones Newswires
March 17, 2017 11:17 ET (15:17 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024